1. Home
  2. RAMP vs VCEL Comparison

RAMP vs VCEL Comparison

Compare RAMP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$25.72

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$29.34

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
VCEL
Founded
2018
1989
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
RAMP
VCEL
Price
$25.72
$29.34
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$35.60
$58.50
AVG Volume (30 Days)
717.9K
610.3K
Earning Date
02-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
1.14
0.32
Revenue
$745,580,000.00
$276,259,000.00
Revenue This Year
$11.20
$19.10
Revenue Next Year
$9.18
$17.95
P/E Ratio
$22.72
$96.31
Revenue Growth
13.02
16.45
52 Week Low
$21.71
$29.24
52 Week High
$35.20
$45.97

Technical Indicators

Market Signals
Indicator
RAMP
VCEL
Relative Strength Index (RSI) 41.13 30.35
Support Level $24.83 N/A
Resistance Level $29.05 $38.48
Average True Range (ATR) 1.01 1.52
MACD -0.39 -0.18
Stochastic Oscillator 11.11 9.09

Price Performance

Historical Comparison
RAMP
VCEL

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: